Healthcare provider profile · identity verified

Malvika Varma, M.D.

Geriatric Medicine · TUCSON, AZ · NPI 1790037141

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Trazodone Hcl	Trazodone Hcl	1244	91
Levothyroxine Sodium	Levothyroxine Sodium	851	45
Pravastatin Sodium	Pravastatin Sodium	835	44
Amlodipine Besylate	Amlodipine Besylate	655	39
Atorvastatin Calcium	Atorvastatin Calcium	592	39
Gabapentin	Gabapentin	578	30
Eliquis	Apixaban	552	30
Omeprazole	Omeprazole	540	36
Mirtazapine	Mirtazapine	519	32
Sertraline Hcl	Sertraline Hcl	459	25
Metoprolol Succinate	Metoprolol Succinate	422	25
Lorazepam	Lorazepam	355	33
Losartan Potassium	Losartan Potassium	353	25
Tamsulosin Hcl	Tamsulosin Hcl	323	19
Lisinopril	Lisinopril	308	19
Metformin Hcl	Metformin Hcl	296	17
Escitalopram Oxalate	Escitalopram Oxalate	288	19
Furosemide	Furosemide	286	22
Citalopram Hbr	Citalopram Hydrobromide	285	15
Donepezil Hcl	Donepezil Hcl	265	17
Quetiapine Fumarate	Quetiapine Fumarate	241	17
Carbidopa-Levodopa	Carbidopa/Levodopa	228	13
Divalproex Sodium	Divalproex Sodium	211	15
Metoprolol Tartrate	Metoprolol Tartrate	200	13
Memantine Hcl	Memantine Hcl	197	13
Venlafaxine Hcl Er	Venlafaxine Hcl	186	suppressed
Torsemide	Torsemide	176	15
Risperidone	Risperidone	174	suppressed
Finasteride	Finasteride	172	suppressed
Levetiracetam	Levetiracetam	166	11
Carvedilol	Carvedilol	162	suppressed
Jantoven	Warfarin Sodium	162	suppressed
Potassium Chloride	Potassium Chloride	157	19
Aripiprazole	Aripiprazole	134	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	133	29
Lamotrigine	Lamotrigine	132	suppressed
Olanzapine	Olanzapine	124	suppressed
Lactulose	Lactulose	116	12
Midodrine Hcl	Midodrine Hcl	116	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	109	12
Paroxetine Hcl	Paroxetine Hcl	107	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	103	103
Duloxetine Hcl	Duloxetine Hcl	103	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	100	suppressed
Famotidine	Famotidine	94	suppressed
Latanoprost	Latanoprost	93	17
Baclofen	Baclofen	85	suppressed
Jardiance	Empagliflozin	84	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	83	suppressed
Ropinirole Hcl	Ropinirole Hcl	76	suppressed
Prednisone	Prednisone	74	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	72	suppressed
Buspirone Hcl	Buspirone Hcl	71	suppressed
Clopidogrel	Clopidogrel Bisulfate	71	suppressed
Tramadol Hcl	Tramadol Hcl	71	suppressed
Alendronate Sodium	Alendronate Sodium	70	suppressed
Hydralazine Hcl	Hydralazine Hcl	68	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	68	suppressed
Bupropion Xl	Bupropion Hcl	67	suppressed
Letrozole	Letrozole	65	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	65	37
Tradjenta	Linagliptin	65	suppressed
Allopurinol	Allopurinol	63	suppressed
Bupropion Hcl	Bupropion Hcl	63	suppressed
Colchicine	Colchicine	61	suppressed
Methimazole	Methimazole	61	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	61	suppressed
Atenolol	Atenolol	59	suppressed
Xarelto	Rivaroxaban	58	suppressed
Hydrocortisone	Hydrocortisone	57	suppressed
Methenamine Hippurate	Methenamine Hippurate	54	suppressed
Glipizide Er	Glipizide	53	suppressed
Amantadine	Amantadine Hcl	50	suppressed
Erythromycin	Erythromycin Base	48	13
Nuplazid	Pimavanserin Tartrate	47	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	suppressed
Albuterol Sulfate	Albuterol Sulfate	44	suppressed
Verapamil Er	Verapamil Hcl	44	suppressed
Amiodarone Hcl	Amiodarone Hcl	43	suppressed
Budesonide	Budesonide	43	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	43	suppressed
Calcium Acetate	Calcium Acetate	42	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	42	15
Aranesp	Darbepoetin Alfa In Polysorbat	41	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	41	suppressed
Digoxin	Digoxin	41	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	41	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	40	suppressed
Ibuprofen	Ibuprofen	38	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	suppressed
Alprazolam	Alprazolam	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	17
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Estradiol	Estradiol	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	19
Divalproex Sodium Er	Divalproex Sodium	33	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	33	suppressed
Incruse Ellipta	Umeclidinium Bromide	33	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Glipizide	Glipizide	32	suppressed
Novolog	Insulin Aspart	32	suppressed
Perphenazine	Perphenazine	31	suppressed
Clomipramine Hcl	Clomipramine Hcl	29	suppressed
Ondansetron Odt	Ondansetron	29	suppressed
Creon	Lipase/Protease/Amylase	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Enalapril Maleate	Enalapril Maleate	27	suppressed
Felbamate	Felbamate	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	11
Labetalol Hcl	Labetalol Hcl	27	suppressed
Levocarnitine	Levocarnitine (With Sugar)	27	suppressed
Oxcarbazepine	Oxcarbazepine	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Xeljanz	Tofacitinib Citrate	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Liothyronine Sodium	Liothyronine Sodium	26	suppressed
Lithium Carbonate	Lithium Carbonate	26	suppressed
Methotrexate	Methotrexate Sodium	26	suppressed
Nadolol	Nadolol	26	suppressed
Trintellix	Vortioxetine Hydrobromide	26	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	16
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	12
Diltiazem Hcl	Diltiazem Hcl	20	suppressed
Levofloxacin	Levofloxacin	20	13
Xifaxan	Rifaximin	20	suppressed
Clobazam	Clobazam	19	suppressed
Cartia Xt	Diltiazem Hcl	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Clozapine	Clozapine	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Dupixent Pen	Dupilumab	16	suppressed
Levemir	Insulin Detemir	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Tivicay	Dolutegravir Sodium	16	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Prevalite	Cholestyramine	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Cephalexin	Cephalexin	14	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lamivudine	Lamivudine	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Metolazone	Metolazone	13	suppressed
Diazoxide	Diazoxide	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Linezolid	Linezolid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error